Table 1.
Demographic Data
| Variable | (n = 16) D/T(−) | (n = 18) D/T(+) | (n = 20) D/T(+)/A/E2(−) | (n = 20) D/T(+)/A/E2(+) | ANOVA P |
|---|---|---|---|---|---|
| Age, y | 64 ± 0.8 | 66 ± 1.0 | 65 ± 1.0 | 65 ± 1.2 | 0.69 |
| BMI, kg/m2 | 28.1 ± 1.1 | 27.7 ± 0.8 | 25.4 ± 0.5 | 26.9 ± 0.9 | 0.12 |
| TSH, mU/L | 2.33 ± 0.2 | 2.76 ± 0.3 | 2.83 ± 0.3 | 2.90 ± 0.3 | 0.44 |
| Prolactin, µg/L | 9.2 ± 0.9 | 8.4 ± 0.6 | 8.7 ± 0.7 | 8.3 ± 0.6 | 0.81 |
| T, ng/dL | 430 ± 30 | 430 ± 21 | 480 ± 22 | 500 ± 28 | 0.11 |
| E2, pg/mL | 22.6 ± 2.5 | 21.4 ± 1.6 | 27.2 ± 1.3 | 24.7 ± 1.3 | 0.08 |
| SHBG, nmol/L | 45 ± 3.3 | 43 ± 3.2 | 42 ± 2.7 | 50 ± 3.3 | 0.35 |
| LH, U/L | 5.0 ± 0.9 | 4.0 ± 0.4 | 5.5 ± 0.8 | 4.0 ± 0.4 | 0.23 |
| FSH, U/L | 9.1 ± 1.0 | 6.6 ± 0.7 | 9.9 ± 1.3 | 6.8 ± 0.6 | 0.12 |
Groups: D/T(−), degarelix + placebo + placebo + no E2 patch; D/T(+), degarelix + T + placebo + no E2 patch; D/T(+)/A/E2(−), degarelix + T + anastrozole + no E2 patch; D/T(+)/A/E2(+), degarelix + T + anastrozole + E2 patch.